Posts

Posted on

XpresSpa Group Announces $41.66 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) — XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced that it has entered into securities purchase agreements with several healthcare-focused and other institutional investors to purchase 24,509,806 of its shares of common stock (or common stock equivalents in lieu thereof) and short-term warrants to purchase up to an aggregate of 24,509,806 shares of common stock, in a registered direct offering priced at-the-market under Nasdaq rules. The combined purchase price for one share of common stock (or common stock equivalent) and a warrant to purchase one share of common stock is $1.70. The warrants have an exercise price of $1.70 per share, will be immediately exercisable, and will expire 24 months from the issue date.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

The gross proceeds from the registered direct offering are expected to be approximately $41.66 million before deducting placement agent fees and other offering expenses. The Company intends to use the net proceeds for future locations, as well as for working capital and general corporate purposes. The registered direct offering is expected to close on or about December 21, 2020, subject to the satisfaction of customary closing conditions.

The securities described above are being offered pursuant to a “shelf” registration statement (File No. 333-240084) filed with the Securities and Exchange Commission (SEC) and declared effective on August 5, 2020. Such securities may be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A prospectus supplement and the accompanying prospectus relating to the offering of the securities will be filed with the SEC. Electronic copies of the prospectus supplement and the accompanying prospectus relating to the offering of the securities may be obtained, when available, on the SEC’s website at http://www.sec.gov or by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by e-mail: [email protected] or by telephone: (646) 975-6996.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor there any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

About XpresSpa Group, Inc.

XpresSpa Group, Inc. (Nasdaq: XSPA) is a health and wellness holding company. XpresSpa Group’s core asset, XpresSpa, is a leading airport retailer of spa services and related health and wellness products, with 50 locations in 25 airports globally. Through its XpresTest, Inc. subsidiary, the Company also provides COVID-19 screening and testing under its XpresCheck™ brand at JFK International Airport and Newark Liberty International Airport. To learn more about XpresSpa Group, visit www.XpresSpa.com. To learn more about XpresCheck, visit www.XpresCheck.com. 

Forward-Looking Statements

This press release may contain “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words “believes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “should,” “seeks,” “future,” “continue,” or the negative of such terms, or other comparable terminology. These statements include, without limitation, statements related to our ability to close the offering and the gross proceeds from the offering. Forward-looking statements relating to expectations about future results or events are based upon information available to XpresSpa as of today’s date and are not guarantees of the future performance of the company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in XpresSpa’s most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q, recent Current Reports on Form 8-K and other Securities and Exchange Commission filings. All subsequent written and oral forward-looking statements concerning XpresSpa, or other matters and attributable to XpresSpa or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XpresSpa does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof, except as required by law.

Investor Relations

ICR
Raphael Gross
(203) 682-8253



Posted on

Versapay Again Named a Leader in the IDC MarketScape: Worldwide SaaS and Cloud-Enabled Midmarket Accounts Receivable Automation Software

PR Newswire

TORONTO, Dec. 17, 2020 /PRNewswire/ – Versapay Corporation, the leader in Customer-Centric Order-to-Cash solutions, has been named a Leader in the recently published IDC MarketScape: Worldwide SaaS and Cloud-Enabled Midmarket Accounts Receivable Automation Software 2020-2021 Vendor Assessment, December 2020, IDC#US47032320.

The report highlights Versapay’s strengths in collections and analytics, self-service and collaboration, and payments, stating: “The platform consistently achieves strong buyer adoption and drives material savings for suppliers through faster payment, reduced processing costs, removal of manual processes, and customer self-service.”

“The events of the past year have made it clear just how critical convenience and digitization are in creating strong customer experiences,” stated Kevin Permenter, Senior Research Analyst, IDC. “Forward-thinking companies are transforming their AR processes to remove friction from the billing and payment experience, a goal that Versapay supports.”

“We’re excited to be recognized as a Leader for the second year by IDC MarketScape through their comprehensive market research,” said Craig O’Neill, Chief Executive Officer of Versapay. “We’re focused on simplifying buyers’ and sellers’ experience throughout the entire order-to-cash process, and this report confirms that our customer-centric approach highly resonates with the market.”

Versapay was also named in Deloitte’s 2020 Technology Fast 500 report and recently announced its merger with Solupay, creating a B2B Payments network supporting 500,000 end-customers.

About IDC MarketScape

IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

About Versapay

Versapay is focused on changing the way companies do business together by offering Customer-Centric Order-to-Cash solutions and B2B Payments for mid-market and enterprise businesses. We help our clients offer a superior customer experience, enabling CFOs to accelerate cash conversion, streamline payments, and digitally transform manual business processes. Based in Toronto with offices in Atlanta, Cleveland, Baltimore, and Las Vegas, Versapay is owned by Great Hill Partners, a Boston-based technology investment firm.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/versapay-again-named-a-leader-in-the-idc-marketscape-worldwide-saas-and-cloud-enabled-midmarket-accounts-receivable-automation-software-301195420.html

SOURCE VersaPay Corporation

Posted on

Kiromic Announces Submission of Two IND Applications for PD1 Gamma-delta CAR – T cell Therapy with the FDA

Kiromic Announces Submission of Two IND Applications for PD1 Gamma-delta CAR – T cell Therapy with the FDA

HOUSTON–(BUSINESS WIRE)–Kiromic BioPharma (“the Company”) (NASDAQ: KRBP), a target discovery and gene-editing company utilizing artificial intelligence and its proprietary neural network platform with a therapeutic focus on immuno-oncology, announced today the submission of two investigational new drug (IND) applications with the U.S. Food and Drug Administration (FDA) for the initiation of:

— Phase 1 clinical trial of an intravenously (IV) administered allogenic CAR-T for epithelial ovarian carcinoma (EOC) and malignant pleural mesothelioma (MPM) and

— Phase 1 clinical trial of an intrapleural/intraperitoneal (IP) administered allogenic CAR-T for EOC and MPM.

Kiromic’s proprietary PD1 Gamma-delta CAR (PD1-GDT CAR) T cell therapy is a novel method for “off-the-shelf” allogeneic CAR T cells derived from healthy donors. We believe our proprietary gamma-delta T cell manufacturing and distribution will offer significant advantages over competitive manufacturing technologies.

The initial dose escalation component of each CAR-T trial is projected to enroll approximately 12 patients over 4 months at two sites.

The first in-human dosing is targeted for 1Q-2021.

“It’s an exciting time to see our technology go into the clinic. This is the culmination of +25 years of research and development which has spanned the globe with international contributions and scientific collaborations from the sharpest minds of our time. Our gamma-delta T-cells are designed to offer clinicians a treatment option with:

— higher efficacy,

— higher safety (reducing graft vs. host risks), and

— lower manufacturing and distribution costs vs. cellular therapy technologies of the past,” says Dr. Maurizio Chiriva-Internati, PhD, CEO of Kiromic.

“This first in-human off-the-shelf allogenic gamma-delta chPD1 CAR-T cell therapy trial will mark a major milestone, not only for Kiromic, but also for clinicians who have been frustrated with the lack of CAR T cell treatment options for solid malignancies, since current CAR T cell therapies are only approved for hematologic malignancies, with all of the drawbacks of autologous based platforms,” commented Dr. Scott Dahlbeck, MD, Chief Medical Officer of Kiromic.

“The cGMP suite consists of 5 clean rooms which will be used to manufacture the Company’s off-the-shelf allogeneic therapies during clinical trials. The Company is fully ready for this IND filing and has the clinical manufacturing capability to supply its clinical trials,” commented Mr. Tony Tontat, CFO, COO of Kiromic.

“Kiromic’s proprietary PD1 Gamma-delta CAR (PD1-GDT CAR) T cell therapy is a novel method for “off-the-shelf” allogeneic CART T Cells derived from healthy donors. As we continue to grow our targets and our clinical programs, our IP portfolio is continually being fortified in all major geographies, and we look forward to updating our investors in upcoming presentations and filings,” commented Mr. Gianluca Rotino, Chief of Strategy and Innovations of Kiromic.

About Epithelial Ovarian Carcinoma

Ovarian tumors grow rapidly and metastasize early with a very aggressive disease course, either through direct extension from the ovarian/fallopian tumor to neighboring organs (bladder/colon), or by detaching from the primary tumor, and then spreading and adhering to intraperitoneal organs.

Epithelial ovarian carcinoma represents the vast majority of ovarian cancers and the most common histologic subtype is high grade serous epithelial ovarian carcinoma. Unlike most other cancers, ovarian carcinoma rarely disseminates through the vasculature, although pelvic and/or para-aortic lymph nodes can be involved. When ovarian cancer spreads to the mesothelium of the organs within the peritoneal cavity, it can result in encasement of these organs with significant pain and eventual obstruction of the stomach, large, and small intestines.

Despite advances in surgical techniques and intensive combination chemotherapy approaches, the survival rate substantially decreases after ovarian cancer has metastasized to pelvic organs (such as the uterus, fallopian tubes, bladder, and rectum), metastasized across the pelvic cavity to the abdominal organs and tissue (such as the omentum, small intestine, and retroperitoneal lymph nodes), or metastasized beyond the peritoneal cavity to distant parenchymal organs such as the liver and lung.

The ovarian cancer tumor microenvironment (TME) within the peritoneal cavity is a key element in the support of ovarian cancer growth, and only by addressing the TME, along with the ovarian cancer tumor cell itself, will significant advances be achieved.

Since ovarian cancer 5 year survival statistics have improved only slightly over the last few decades, innovative approaches such as Kiromic’s administration of a PD1-GDT CAR, which is designed to address the TME of EOC, are desperately needed.

About Malignant Pleural Mesothelioma

Patients with a diagnosis of mesothelioma are generally considered to be incurable, and typically present late, with multiple signs and symptoms such as shortness of breath, chest pain, cough, hemoptysis, dysphagia, weight loss, fatigue, night sweats, and face/arm swelling which often precludes surgical options. Chemotherapy and radiation therapy are also options but are often only palliative, with or without an attempted surgical resection.

If the patient is one of the few considered to be a surgical candidate, the surgical objective will be to obtain a maximal cellular reduction (MCR), followed by chemotherapy +/- radiation therapy. Yet even with an MCR and adjuvant therapies, the vast majority of patients still experience a recurrence, most of which are local, and when the tumors do recur, second line treatments are essentially palliative.

Hence, the majority of patients suffering from this disease need innovative and novel treatment options, as most patients will ultimately die of their disease with a poor remaining quality of life due to symptoms such as severe shortness of breath and chest pain, due to hardening of the pleura associated with the inevitable disease progression. Innovative approaches such as Kiromic’s administration of a PD1-GDT CAR, which is designed to address the tumor microenvironment (TME) of MPM are urgently needed.

About Kiromic

Kiromic BioPharma, Inc. is a preclinical stage biopharmaceutical company which is focused on discovering, developing, and commercializing novel immune-oncology applications through its robust product pipeline. The pipeline development is leveraged through the Company’s proprietary target discovery engine called “DIAMOND.” Kiromic’s DIAMOND is big data science meeting target identification, dramatically compressing man-years and billions of drug development dollars to develop a live drug. The Company maintains offices in Houston, Texas.

For more information, please visit the company’s website at www.kiromic.com.

Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. We make such forward-looking statements pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act, Section 21E of the Securities Exchange Act of 1934, as amended, and other federal securities laws. All statements other than statements of historical facts are forward-looking statements. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about:

  • our goals and strategies;
  • our future business development, financial condition and results of operations;
  • expected changes in our revenue, costs or expenditures;
  • growth of and competition trends in our industry;
  • our expectations regarding demand for, and market acceptance of, our products;
  • our expectations regarding our relationships with investors, institutional funding partners and other parties we collaborate with;
  • fluctuations in general economic and business conditions in the markets in which we operate; including those fluctuations caused by COVID-19; and
  • relevant government policies and regulations relating to our industry.

In some cases, you can identify forward-looking statements by terms such as “may,” “could,” “will,” “should,” “would,” “expect,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “project” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under the heading “Risk Factors” included in our Registration Statement on Form S-1 (file no. 333-238153) , originally filed with the Securities and Exchange Commission (SEC) on May 11, 2020, as amended, and elsewhere in this press release. If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance.

The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. Except as expressly required by the federal securities laws, there is no undertaking to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changed circumstances or any other reason. You are advised, however, to review any further disclosures we make on related subjects in our Forms 10-Q, 8-K and other reports filed with the SEC.

Tony Tontat

Chief Financial Officer

(844) 539 – 2873

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Biotechnology Health Pharmaceutical Clinical Trials Oncology

MEDIA:

Logo
Logo
Posted on

Aim-X Canada isolation gowns and easy to breathe through masks pass CSA protection guidelines

VANCOUVER, British Columbia, Dec. 17, 2020 (GLOBE NEWSWIRE) — CSA testing has confirmed that Aim-X Canada surgical masks are easy to breathe through and isolation gowns are quality products that Canadians can depend on for COVID-19 protection.

“We’re happy with the results,” said Aim-X Canada Enterprises Ltd. CEO H. Hassan. “Samples of our three-Ply Disposable Tri-fold Level 1 non-medical masks and Level 1 Isolation Gowns have passed industry standard tests for medical PPE.”

This confirms the company can deliver quality products manufactured by Aim-X Global to medical facilities, governments, and the public. CSA Certificates of Attestation are available upon request.

Sample masks sent to CSA were tested against the ASTM F2100 Standard Specification for Performance of Materials Used in Medical Faces Masks. This is the standard in North America for masks in the Medical Industry.

These standards include requirements for bacterial filtration effectiveness for particle filtration efficiency, flammability, and fluid resistance.

CSA confirmed Aim-X Level 1 Masks met the requirements of medical masks with a bacterial and a particular filtration efficiency greater than 95 percent. The masks were also found to be resistant to fluid penetration pressure of approximately 10.66kPa (1.5 psi).

The ASTM F2100 standards also require Level 1 Masks have a differential pressure of less than or equal to 5.0 mm H2O/cm2. The lower the number, the easier it is to breathe though.

“What’s impressive is the results have also confirmed the masks are extremely easy to breathe through. The sample masks tested were only 1.66 mm H2O/cm2,” said Hassan.

The isolation gowns were tested against the ANSI/AAMI PB70 standard. This is the standard applied around the world for testing surgical and isolation gowns in the medical industry.

Tests were conducted on the gowns following the American Association of Textile Chemists and Colorists procedures. It tested the front panel, back, sleeves, and the seams of the gowns for impact penetration and resistance to hydrostatic pressure.

“It found out that our Level 1 gowns reduced liquid penetrating the fabric when subjected to a continuous stream of liquid from a height of 50 cm for 20 seconds,” said Hassan.

Aim-X Canada Enterprises Ltd. will continue to have its products tested at reputable Canadian testing facilities. Selling quality products is a core pillar of Aim-X Canada’s business model. Shortly, it will be testing its Aim-X Type 1R & 2R Masks and Aim-X Body Suits.

All Aim-X Canada products have been licensed through Health Canada and adhere to Health Canada regulations.

Health Canada has provided this information to allow individuals to assess their risk profile for the virus. Individuals may select products like Aim-X Class 1 medical masks that provide a higher level of protection. These products must meet the international standards for Class I medical devices.

“Health Canada does not endorse any standards for face coverings at this time. We are actively monitoring any developments to revise our products when new information becomes available,” said Hassan.

Aim-X Canada Enterprises Ltd. is the Canadian distributor for Aim-X Global. AIM-X Global manufactures a full range of personal protection equipment for organizations or personal use, including P15 ventilators, testing kits, masks, face shields, surgical gloves, gowns, and other devices, and customizable kits for every need around the world.

Since Aim-X is both the manufacturer and distributor, it can customize PPE kits tailored for different industries such as schools, small businesses, hospitals, travelers and general workers. It also has kits to respond to an epidemic outbreak. These kits are stocked with the same quality individual products that are available to the consumer.

Bulk or single orders can be placed on the Aim-X Canada website for Canada or U.S. delivery. Products are distributed from Vancouver, B.C. and by S3 Aim-X USA warehouses across the U.S.

For further information contact Hassan at (604) 715-4988 or [email protected]

FOR FURTHER INFORMATION:

Hassan Hassan

CEO


Aim


-X Canada Enterprises Ltd.


#1518-800 West Pender Street

Vancouver, BC Canada V6C 2V6

Phone:
(604) 715-4988

Email:
[email protected] 



Posted on

SeaWorld, Pacific Marine Mammal Center, and University of Florida Establish Health Markers for Dolphins to Support the Health of the Species around the World

Critical research over a three-year period is vital to helping diagnose dolphin health, disease, and stressors

PR Newswire

SAN DIEGO, Dec. 17, 2020 /PRNewswire/ — Following SeaWorld’s 2019 publication of a foundational study that created first-ever standards for assessing the health of killer whales, this same team of veterinarians from SeaWorld, the Pacific Marine Mammal Center, and the University of Florida College of Veterinary Medicine has published a similar study about dolphin health in Veterinary Quarterly. Using data from 1,426 blood samples collected as part of SeaWorld’s routine preventative medicine program from 156 healthy bottlenose dolphins at SeaWorld Orlando, San Antonio, and San Diego parks, experts were able to define health benchmarks that can be used by other veterinarians and conservation biologists to help improve the diagnosis of health, disease, and stressors of wild dolphin populations.

Bottlenose dolphins in the United States are protected under the Marine Mammal Protection Act because they are vulnerable to many threats. These can include disease, biotoxin, pollution, habitat alteration, interactions with commercial and recreational fishing, energy exploration and oil spills, and other types of human disturbance (such as underwater noise).

“It is very difficult to assess the health of a wildlife species, to in turn be able to help them, because they are typically very challenging to access and their individual histories are largely unknown,” said Dr. Hendrik Nollens, Pacific Marine Mammal Center’s Vice President of Conservation Medicine and Science and study lead author. “Our study not only reports on what normal looks like in a large population of healthy dolphins with a known medical history, but we also compare what normal looks like across several populations of dolphins, both in human care and in the wild. SeaWorld has uniquely equipped, on-site veterinary diagnostic laboratories that generate high quality health data that can be shared with the scientific community.”

Similar to the earlier report on standards for assessing health in killer whales, the ability to collect blood-based health data of dolphins in a reliable, controlled manner provides a unique opportunity for scientists to understand the species’ physiology. The results of managed population studies are also very valuable because veterinarians can conduct longer-term follow-up of those same dolphins to track their known age, health, reproductive and nutritional statuses. Not only are dolphins able to participate in such studies as part of their routine preventative medical care at SeaWorld, they are trained to participate in their health care such as presenting the underside of their tail – or fluke – so a veterinary professional can draw a blood sample.

“We had the opportunity to work closely with one of our former undergraduate students on this research study,” said Dr. Nicole Stacy, Clinical Assistant Professor of Aquatic, Amphibian and Reptile Pathology, College of Veterinary Medicine, University of Florida. “The dataset was very unique given the number of animals in the study and their broad age range, which in turn provides many applications for the results to benefit cetacean research and conservation.”

“Similar to how your primary care doctor checks your weight, blood pressure and overall health and compares the results against a benchmark for human health, this research provides the same benefit to the dolphin population,” said Dr. Todd Robeck, SeaWorld Vice President of Conservation Research and study author. “We need to find ways to take better care of the animals in our oceans through research, rescue, animal care and conservation efforts, and my research partners and I are happy to share the results of this study with other scientists and animal welfare experts around the world to help do this.”

About SeaWorld Entertainment, Inc.

SeaWorld Entertainment, Inc. (NYSE: SEAS) is a leading theme park and entertainment company providing experiences that matter, and inspiring guests to protect animals and the wild wonders of our world. The Company is one of the world’s foremost zoological organizations and a global leader in animal welfare, training, husbandry and veterinary care. The Company collectively cares for one of the largest zoological collections in the world and has helped lead advances in the care of animals. The Company also rescues and rehabilitates marine and terrestrial animals that are ill, injured, orphaned or abandoned, with the goal of returning them to the wild. The SeaWorld® rescue team has helped more than 36,000 animals in need over the Company’s history.  SeaWorld Entertainment, Inc. owns or licenses a portfolio of recognized brands including SeaWorld®, Busch Gardens®, Aquatica®, Sesame Place® and Sea Rescue®. Over its more than 60-year history, the Company has built a diversified portfolio of 12 destination and regional theme parks that are grouped in key markets across the United States, many of which showcase its one-of-a-kind zoological collection. The Company’s theme parks feature a diverse array of rides, shows and other attractions with broad demographic appeal which deliver memorable experiences and a strong value proposition for its guests.

Copies of this and other news releases as well as additional information about SeaWorld Entertainment, Inc. can be obtained online at www.seaworldentertainment.com. Shareholders and prospective investors can also register to automatically receive the Company’s press releases, SEC filings and other notices by e-mail by registering at that website.

About Pacific Marine Mammal Center

The Pacific Marine Mammal Center rescues, rehabilitates and releases marine mammals and inspires ocean stewardship through research, education and collaboration. PMMC is a non-profit 501 (c)(3) organization. Our Tax-ID number is: 95-3680896

20612 Laguna Canyon Road | Laguna Beach, California, 92651 | (949) 494-3050

About the University of Florida College of Veterinary Medicine

The University of Florida College of Veterinary Medicine, the state’s only veterinary college, is supported through funding from UF Health and the UF Institute of Food of Agricultural Sciences, (UF-IFAS). The college’s Aquatic Animal Health program focuses on the health of marine mammals and other aquatic species and is funded in part by the Florida Fish and Wildlife Conservation Commission.

Contact: Stephen Schuler, [email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/seaworld-pacific-marine-mammal-center-and-university-of-florida-establish-health-markers-for-dolphins-to-support-the-health-of-the-species-around-the-world-301195408.html

SOURCE SeaWorld Parks & Entertainment

Posted on

The Far Future of Next Generation Wireless Communications

5G Americas provides overview of Next G industry research and activities highlighting the evolution and future of mobile wireless networks

BELLEVUE, Wash., Dec. 17, 2020 (GLOBE NEWSWIRE) — With 5G networks having just finished their second year in existence, wireless industry leaders are already exploring the path to future wireless networks beyond 5G. 5G Americas the wireless industry trade association and voice of 5G and LTE for the Americas, today announced the publication of a white paper Mobile Communications Beyond 2020 – The Evolution of 5G Towards Next G, which details this global work from several academic and industry organizations and presents potential use cases and technologies integral to the evolution of 5G towards the “Next G”.

Chris Pearson, President of 5G Americas said, “5G is in the second inning of a nine-inning baseball game with a huge roadmap of innovation ahead. Yet, the mobile wireless industry is going through a transformational change right now. Despite COVID, industries and societies are rapidly digitizing, so it is imperative that conversations around the next generation of mobile cellular wireless technologies begin to take place.”

While 5G is still early in its lifecycle, it continues to be enhanced through continuous updates via Third Generation Partnership Project (3GPP) releases. These enhancements to networks, architecture, technologies, and standards will continue through 3GPP Release 17 and beyond. However, it is expected over the next few years, that requirements for the next generation of mobile wireless will be outlined in the upcoming International Mobile Telecommunications 2030 (IMT-2030) update from the International Telecommunications Union (ITU).

Early thought leadership around next generation wireless use cases may include scenarios involving tactile or haptic communications, high resolution terahertz spectrum use for imaging and sensing, cyber-physical systems in manufacturing, and enhanced public safety and national security applications.

This 5G Americas white paper covers the three main topics:

  • A review of activities looking beyond 5G in both North America and globally
  • How communications will change beyond the 2020s, including several use cases
  • How North America can establish and maintain technological leadership in future communications standards

Brian Daly, Assistant Vice President, Standards & Industry Alliances AT&T and leader of the working group in development of this white paper said, “Many projects identified as ‘Next G’ and ‘6G’ identified projects are proceeding globally with some contribution from the Americas. There is a need for commercial entities, government agencies and academic bodies in the United States to be at forefront of these next generation developments.”

Mark Lipford, Director Industry Forums and Relations, T-Mobile USA commented, “5G will deliver many years of value and innovative services to customers, but it’s important to begin to consider vision and the goals that the ITU will lay down for IMT-2030 for the following decade.”

The paper Mobile Communications Beyond 2020 – The Evolution of 5G Towards Next G is available for free download on the 5G Americas website. Blog post by Chris Pearson, and presentation slides are also featured on the 5G Americas website.

About 5G Americas: The Voice of 5G and LTE for the Americas

5G Americas is an industry trade organization composed of leading telecommunications service providers and manufacturers. The organization’s mission is to facilitate and advocate for the advancement and transformation of LTE, 5G and beyond throughout the Americas. 5G Americas is invested in developing a connected wireless community while leading 5G development for all the Americas. 5G Americas is headquartered in Bellevue, Washington. More information is available at 5G Americas website and Twitter.

5G Americas’ Board of Governors Members include AT&T, Cable & Wireless, Ciena, Cisco, CommScope, Crown Castle, Ericsson, Intel, Mavenir, Nokia, Qualcomm Incorporated, Samsung, Shaw Communications Inc., T-Mobile US, Inc., Telefónica, VMware and WOM.

Contact:
5G Americas
Viet Nguyen
+1 206 218 6393
[email protected]



Posted on

Perfetti Van Melle USA Appoints Wavemaker as Media Agency of Record

NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) — Wavemaker announced today that it has been named Media Agency of Record (AOR) by Perfetti Van Melle USA, one of the world’s largest manufacturers and distributors of confectionary and gum, including global and regional brands such as Mentos, Airheads, Chupa Chups, and newly launched Fruit-tella. The appointment is effective immediately.

The confectioner sought to consolidate its global agency roster and integrate its business, and selected Wavemaker following a review for its strong track record of innovation and proven expertise driving growth for consumer-packaged goods (CPG) brands.

“A key differentiator for Wavemaker was its ability to fuse global and local expertise across multiple disciplines, from media and data sciences to ecommerce and shopper media,” said Rachel Chambers, Vice President, Marketing, Perfetti Van Melle USA.

“We’re thrilled to partner with Perfetti Van Melle to connect with consumers in ways that are both playful and sales predictive,” said Amanda Richman, CEO, Wavemaker, US.

The appointment expands Wavemaker’s global relationship with the candy-maker, which now spans the US, China, Netherlands, India, UK, MENA, Belgium, Turkey and Indonesia.

Perfetti Van Melle acted quickly to pivot its portfolio strategy amid the pandemic to ensure sales remained strong. Likewise, Wavemaker’s business success has been a bright spot amongst agencies this year, despite the headwinds of a recession. With an incredible track record driving growth for clients, Wavemaker has had significant new business wins, strong organic growth, 100% client retention and impressive data product innovation during a chaotic year for the advertising industry.

About Wavemaker

We believe there always is a better way to grow. We positively provoke growth for our clients by reshaping consumer decision-making and experiences through media, content and technology. The Wavemaker way is globally consistent. Fueled by the world’s most powerful consumer data, we understand where and how marketing can intervene decisively to help brands win more sales. Our 7,200 people across 90 markets have the deep knowledge, confidence and courage to provoke growth for some of the world’s leading brands and businesses.

We are a part of GroupM, WPP’s global media investment management company. Discover more on wavemakerglobal.com, Twitter and LinkedIn.

About Perfetti Van Melle:
Perfetti Van Melle is a privately owned global company that was established in March 2001 through the merger of Perfetti SpA and Van Melle Group B.V. Perfetti Van Melle manufactures and markets sugar confectionery and chewing gum products in more than 150 countries. Today, Perfetti Van Melle is one of the world’s largest confectionery groups, marketing highly renowned brands such as Mentos, Frisk, Chupa Chups, Smint, Fruit-tella, Alpenliebe, Golia, Vivident, Airheads, Happydent & Big Babol. The Group has corporate headquarters in Italy and The Netherlands. U.S. operations are operated solely out of Erlanger, KY.

Contact

Kaya Heitman
Managing Partner, Marketing & Communications, US, Wavemaker
[email protected]



Posted on

Loop Insights Partners With NTT DATA, Top Ranked Global IoT Services Company And Subsidiary Of Nippon Telegraph and Telephone, World’s 4th Largest Telecom Ranked 55th In Fortune Global 500

Partnership Marks Loop Insights’ Most Significant Partnership To Date

VANCOUVER, British Columbia, Dec. 17, 2020 (GLOBE NEWSWIRE) — Loop Insights Inc. (MTRX:TSXV; RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the signing of a global partnership agreement with NTT DATA Corp of Japan (TYO:9613), a global leader in technology services and a top-ranked global Internet of Things (IoT) consulting and system integration services company, with $USD 20-billion in revenues in 2020. The two companies are working towards a finalized agreement with no financial commitments agreed upon at this time.

Loop and NTT DATA intend to combine their respective strengths to create new recurring revenue models for both companies. For example, the NTT Smart platform, first introduced as a solution in building smarter, more connected cities, is now the cornerstone for its Back to Business Application. Integrating Loop’s Insights and automated marketing capabilities with the NTT Smart Platform in a seamless manner is an obvious fit for both companies, each of which stands to benefit from the integration.

Loop Insights CEO Rob Anson stated, “Our partnership with NTT establishes Loop Insights as a global provider of IoT solutions for Venue Bubbles and Artificial Intelligence-driven automated marketing. As a result of this partnership, Loop will be exposed to global opportunities never thought possible earlier this year. For example, Loop’s successful live deployment of its Venue Bubble solution and its published capabilities with respect to its Travel Bubble solution will be the subject of work on major projects with NTT DATA. We thank William and his team for their confidence and look forward to accomplishing incredible things together in 2021.”

NTT DATA President William Baver stated, “NTT has developed a data platform to provide reactive and predictive analytics to help organizations achieve situational awareness related to any confined structure or area. This is a natural fit to the travel bubble concept that when paired with the Loop’s venue management solution, will provide our customers with the ability to ingest data from multiple sources and provide insights back via various APIs to allow customers to enjoy the best of both technologies. With respect to the various travel bubbles, we have the ability to bring the data tracking and data wallet details from Loop Insights to combine with situational awareness and data tracking from optical sensors, sound sensors, and other data sources surrounding this environment.”

NTT DATA – A TOP 10 GLOBAL IT SERVICES PROVIDER OPERATING IN MORE THAN 50 COUNTRIES

NTT DATA is a recognized leader in global technology services and a trusted global innovator, delivering technology-enabled services and solutions to clients around the world.

On April 2, 2020, NTT DATA was named “Top Ranked” for their global Internet of Things (IoT) consulting and system integration services by teknowlogy Group – a leading independent European research firm.

On February 6, 2020, the NTT DATA brand was ranked the world’s eighth most valuable brand among IT services providers according to UK-based Brand Finance, the world’s leading brand valuation and strategy consultancy.

Forbes named NTT Data to its list of Best Management Consulting Firms 2020

NTT DATA is a publicly-traded company with 123,000 employees and a current market capitalization of approximately $USD 18.5-billion. NTT DATA is approximately 54% owned by Nippon Telegraph and Telephone Corp.

NIPPON TELEGRAPH AND TELEPHONE CORP – ONE OF THE LARGEST TELECOM COMPANIES IN THE WORLD

Nippon Telegraph and Telephone Corp. (TYO: 9432) (“NTT”) is the fourth-largest telecommunications company in the world in terms of revenue and Ranked 55th in the Fortune Global 500 with a current market cap of approximately $USD 100-billion.

With approximately 310,000 employees worldwide, NTT is chosen by as many as 88% of the top 100 companies in the Global Fortune 500.

Globally NTT is recognized as one of the world’s largest information, communication, and technology companies. NTT’s operations and capabilities span six continents, connecting people and technologies. The depth and breadth of NTT’s global offerings span everything from mobile phones to data centers, with a strong foundation, focus, and corporate commitment to innovation. NTT helps clients achieve their business goals by creating, operating, maintaining, and evolving mission-critical IT systems and business processes.

NTT DATA PARTNERSHIP REPRESENTS SECOND MAJOR IOT PARTNERSHIP FOR LOOP INSIGHTS IN 2020

On October 15th, Loop announced the significant milestone of having been accepted into the Telus IoT Marketplace. The Company’s first product accepted into the IoT Marketplace was its contact tracing product, which has received significant exposure to many of TELUS’s largest customers and ongoing significant discussions with them. The third-party validation that came with this acceptance has been instrumental in Loop’s contact tracing discussions with large corporate customers around the world.

On December 3rd, Loop announced the Launch Of A Second Product Into The TELUS IoT Marketplace For National Sales and Marketing To TELUS Business Customers. The Company’s second product accepted into the IoT Marketplace was our Insights service which consists of our IoT Fobi device, Loop Cloud API, and AI Insights Portal that provide automated marketing capabilities. Connected between the printer and point of sale, Loop’s Fobi device’s real-time capabilities are driven by Artificial Intelligence to enhance the shopping experience. Providing data-driven product suggestions and unique discount codes for future use, Loop enables customers to increase revenues through increased spend per customer.

Loop Insights CEO Robert Anson added, “With two major IoT partnerships on two different continents, Loop is receiving unprecedented third-party validation and exposure to global opportunities that will be instrumental in the potential great success of our company in 2021 and beyond.”

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion And Management Engagement https://agoracom.com/ir/LoopInsights/forums/discussion

About NTT DATA

NTT DATA – a part of NTT Group – is a trusted global innovator of IT and business services headquartered in Tokyo. We help clients transform through consulting, industry solutions, business process services, digital & IT modernization, and managed services. NTT DATA enables them, as well as society, to move confidently into the digital future. We are committed to our clients’ long-term success and combine global reach with local client attention to serve them in over 50 countries around the globe. Visit us at nttdata.com

About Loop Insights

Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.

For more information, please contact:

Loop Insights Inc.   LOOP Website: www.loopinsights.ai
Rob Anson, CEO   Facebook: @ LoopInsights
T : +1 877-754-5336 Ext. 4   Twitter: @ LoopInsights
E : [email protected]   LinkedIn: @ LoopInsights


Forward-Looking Statements/Information:
 

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives. 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 



Posted on

AM Best Affirms Credit Ratings of CVS Health Corporation’s Aetna Subsidiaries

AM Best Affirms Credit Ratings of CVS Health Corporation’s Aetna Subsidiaries

OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other operating entities of Aetna Inc. (Aetna) that are now wholly owned subsidiaries of CVS Health Corporation (CVS Health) [NYSE: CVS]. These entities include the members of Aetna Health & Life Group. Concurrently, AM Best has affirmed the FSR of A- (Excellent) and the Long-Term ICR of “a-” Aetna Insurance Company Limited(AICL) (United Kingdom). The outlook of these Credit Ratings (ratings) is stable. Please see below for a detailed listing of the companies.

AM Best also has affirmed the FSR of A (Excellent) and the Long-Term ICRs of “a” of Texas Health + Aetna Health Insurance Company (Arlington, TX), as well as Texas Health + Aetna Health Plan, Inc., (Arlington, TX) (collectively referred to as Texas Health Aetna), and Allina Health and Aetna Insurance Company (St. Louis Park, MN), all of which are joint ventures with subsidiaries of Aetna Inc. The outlook of these ratings is stable.

Lastly, AM Best has assigned an FSR of A (Excellent) and a Long-Term ICR of “a” to Accendo Insurance Company (Accendo) (West Valley City, UT). Accendo is a newly added member to the Aetna Health & Life Group. The outlook assigned to these ratings is stable. Accendo, licensed in 50 states, has assumed Medicare Part D premium from an affiliate under CVS Health; however, the company recently started writing direct Medicare Supplement business in multiple states. The business written by Accendo targets the senior demographic, and the company expects additional complementary life insurance products to be offered along with traditional Medicare Supplement insurance products.

The majority of Aetna’s operating entities are part of Aetna Health & Life Group. The ratings of Aetna Health & Life Group reflect its balance sheet strength, which AM Best categorizes as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management (ERM).

The ratings also reflect Aetna Health & Life Group’s very strong level of risk-adjusted capitalization, which is driven by strong operating performance. However, this is offset by dividend payments, which have exceeded $2 billion in each of the past three years as the entities have distributed a larger percentage of earnings as dividends compared with prior periods. These higher dividends followed the sale of life and disability business in 2017, as well as lower commercial premium due to exit from individual exchange market. The lead company, ALIC, has reported a decline in risk-based capital to under 200% company action level; however, the company has a planned strategy to increase this above 200% by 2020 and maintain this level.

AM Best considers the group’s operating performance to be strong, with return on equity measures annually at or exceeding 25% with underwriting income that has been greater than $2 billion annually since the acquisition by parent company CVS Health was finalized in 2018. Aetna Health & Life Group reported strong growth in net premiums in 2019, partially attributed to consistent double-digit growth in the Medicare Advantage line of business. Furthermore, SilverScript Insurance Company, a member of the Aetna Health & Life Group, remains the leading stand-alone Medicare Part D plan in the United States, based on market share. Through nine months ended Sept. 30, 2020 and similar to industry trends, CVS’ Health Care Benefits segment has reported lower medical benefit ratios attributed to the decline in utilization during the first half of 2020 as elective procedures were delayed and the health care providers focused on the COVID-19 pandemic. This decline contributed to very strong earnings through the end of the third quarter; however, the company reported an uptick in utilization in the third quarter to more normal levels due to increase in elective procedures and emergency care outside of COVID-19 hot spots.

Aetna is one of the top three U.S. health insurers in terms of medical membership, which has increased to 23.3 million individuals for commercial, Medicare and Medicaid products. Aetna’s Medicare Advantage membership growth has outpaced the industry over the past five years, moving Aetna to the number three insurer from the fifth position in the Medicare Advantage market. As of Sept. 30, 2020, Aetna’s Medicare Advantage members are in plans with a Star rating of 4.0 or higher, exceeding peers and the industry average. The company also has recently reported strong membership growth in Medicaid managed care business, which is due in part to the COVID-19 pandemic and the rise in the unemployment rate as businesses have laid off or furloughed their workforces. The rate has stayed persistently high since the outbreak of the coronavirus. Similar to industry trends, Aetna has seen consistent membership decline in its commercial business.

The ratings of Aetna Health & Life Group reflect high financial leverage and goodwill at the ultimate parent, CVS Health. Financial leverage at the end of third-quarter 2020 was approximately 49%. While AM Best considers that to be high, it remains lower than year-end 2019 as the CVS Health organization is focused on deleveraging. The execution risk related to the Aetna-CVS Health merger has declined over the past year, as many aspects of the management of Aetna’s legacy business is on track and following the transformation plans outlined by management. However, while CVS Health stated its intention to maintain the capitalization level at the insurance entities in aggregate at the NAIC’s company action level of 275%, actual risk-based capital at year-end 2019 was lower than target and the company’s capital plan now includes increasing its risk-based capital ratio in 2020. CVS Health is doing this while keeping to its accelerated deleveraging plan through robust operating earnings at the insurance entities, strong cash flows from operations and suspension of its share repurchase program. CVS Health is expected to play a major part in the distribution of the COVID-19 vaccines in long-term care facilities, as an official COVID-19 Vaccination Program Provider.

The ratings of AICL reflect its balance sheet strength, which AM Best categorizes as very strong, as well as its marginal operating performance, limited business profile and appropriate ERM. Furthermore, the ratings of AICL factor in rating enhancement from the Aetna organization. AICL has benefited from capital injections and the transfer of international business from the wider group.

The ratings of Allina Health and Aetna Insurance Company reflect its balance sheet strength, which AM Best categorizes as strong, as well as its marginal operating performance, limited business profile and appropriate ERM. The ratings include the enhancement from the Aetna organization.

The ratings of Texas Health Aetna reflect its balance sheet strength, which AM Best categorizes as very strong, as well as its adequate operating performance, limited business profile and appropriate ERM. The ratings include the enhancement from the Aetna organization.

The FSR of A (Excellent) and the Long-Term ICRs of “a” have been affirmed with a stable outlook for the following members of Aetna Health & Life Group:

  • Aetna Life Insurance Company
  • Aetna Health and Life Insurance Company
  • Aetna Life & Casualty (Bermuda) Ltd.
  • Aetna Health Inc. (a Connecticut corporation)
  • Aetna Health Inc. (a Florida corporation)
  • Aetna Health Inc. (a Georgia corporation)
  • Aetna Health Inc. (a Louisiana corporation)
  • Aetna Health Inc. (a New Jersey corporation)
  • Aetna Health Inc. (a New York corporation)
  • Aetna Health Inc. (a Maine Corporation)
  • Aetna Health Inc. (a Pennsylvania corporation)
  • Aetna Health Inc. (a Texas corporation)
  • Aetna Health Insurance Company
  • Aetna Health Insurance Company of New York
  • Aetna Health of California Inc.
  • Aetna Health of Iowa, Inc.
  • Aetna Health of Utah, Inc.
  • Aetna Dental of California Inc.
  • Aetna Dental Inc. (a New Jersey corporation)
  • Aetna Dental Inc. (a Texas corporation)
  • American Continental Insurance Company
  • Continental Life Insurance Company of Brentwood, Tennessee
  • Coventry Health and Life Insurance Company
  • Aetna Better Health of Michigan, Inc.
  • Aetna Better Health of Missouri, LLC
  • Coventry Health Care of Illinois, Inc.
  • Coventry Health Care of Kansas, Inc.
  • Coventry Health Care of Florida, Inc.
  • Coventry Health Care of Missouri, Inc.
  • Coventry Health Care of Nebraska, Inc.
  • Coventry Health Care of Virginia, Inc.
  • Coventry Health Care of West Virginia, Inc.
  • First Health Life & Health Insurance Company
  • HealthAssurance Pennsylvania, Inc.
  • SilverScript Insurance Company

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper media use of Best’s Credit Ratings and AM Best press releases, please view Guide for Media – Proper Use of Best’s Credit Ratings and AM Best Rating Action Press Releases.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in New York, London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2020 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Wayne Kaminski

Senior Financial Analyst

+1 908 439 2200, ext. 5061

[email protected]

Stanislav Stoev, ACCA

Financial Analyst

+44 20 7397 6264

[email protected]

Christopher Sharkey

Manager, Public Relations

+1 908 439 2200, ext. 5159

[email protected]

Jim Peavy

Director, Communications

+1 908 439 2200, ext. 5644

[email protected]

KEYWORDS: New Jersey Europe United States North America

INDUSTRY KEYWORDS: Insurance Professional Services

MEDIA:

Logo
Logo
Posted on

Zhaga and the DALI Alliance add sensors and controllers to Zhaga-D4i certification

The product ecosystem for road lighting that can be Zhaga-D4i certified now includes DALI-based sensors and controllers with Zhaga connectors, as well as luminaires.

PISCATAWAY, N.J., Dec. 17, 2020 (GLOBE NEWSWIRE) — The joint Zhaga-D4i certification program from the DALI Alliance and the Zhaga Consortium has already qualified a number of Zhaga-D4i Book 18 outdoor luminaires with Zhaga receptacles and D4i components. Now, certified D4i control devices with Zhaga connectors can also be submitted for Zhaga-D4i certification. Eligible devices include light-level or occupancy sensors, as well as control nodes that can communicate wirelessly with external networks.

This ecosystem of lighting products enables smart, future-proof LED luminaires with IoT connectivity. Certified Zhaga-D4i products can carry the dual logos of Zhaga and D4i which together indicate plug-and-play interoperability of sensors, communication nodes and luminaires.

“Bringing control devices into the Zhaga-D4i program will enable a certified ecosystem of interoperable products from multiple vendors, which will be welcomed by the lighting market,” said Paul Drosihn, DALI Alliance General Manager.

“With the Zhaga-D4i certification program, decision makers in outdoor road lighting can combine the long-lasting nature of the lighting infrastructure with the rapid changes in digital communication and sensor technology,” said Dee Denteneer, Zhaga Secretary-General.

Zhaga-D4i luminaires have a powered Zhaga receptacle, which can accommodate a D4i-certified sensor or communication node with a corresponding Zhaga baseplate. Also, Zhaga-D4i luminaires use LED drivers meeting the D4i requirements, including the availability of DALI luminaire, energy and diagnostics data.

D4i enables DALI in intelligent, IoT-ready luminaires. By taking care of control and power requirements, D4i makes it much easier to mount sensors and communication devices on luminaires.

Smart Zhaga-D4i luminaires are ideal platforms for the IoT, capable of gathering information from on-board D4i sensors, and providing data via DALI for performance monitoring, asset management, predictive maintenance and many other tasks. Communication and data exchange with an external network can take place using a D4i control device with wireless communication capabilities.

About the DALI Alliance

The DALI Alliance (also known as the Digital Illumination Interface Alliance or DiiA) is an open, global consortium of lighting companies that drives the growth of lighting-control solutions based on internationally-standardized Digital Addressable Lighting Interface (DALI) technology. The organization operates the DALI-2 and D4i certification programs to boost levels of cross-vendor interoperability. As lighting continues to evolve and converge with the IoT, the DALI Alliance is also driving the standardization of wireless and IP-based connectivity solutions. For more information, visit www.dali-alliance.org.

About Zhaga

Zhaga is a global association of lighting companies that is standardizing interfaces of components of LED luminaires, including LED light engines, LED modules, LED arrays, holders, electronic control gear (LED drivers) and connectivity fit systems. This helps to streamline the LED lighting supply chain, and to simplify LED luminaire design and manufacturing. Zhaga continues to develop specifications based on the inter-related themes of interoperable components, smart and connected lighting, and serviceable luminaires. For more information, visit www.zhagastandard.org.  

Contact Details

Dee Denteneer
Secretary General, Zhaga Consortium
Email: [email protected]

Paul Drosihn
General Manager, DiiA
Email: [email protected] 

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2bd749bb-c7f4-4c21-8de2-4a0ee9337199